🔎 Trials Near Me

Почетна › Рак (све врсте) › Тексас › Houston

Kliničke studije za Рак (све врсте) u gradu Houston, TX

124 studija za Рак (све врсте) traži učesnike na lokacijama u gradu Houston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Тражи се учесникФаза 3
  • Oncology Consultants PA, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Узраст од 18 до 100 · Оба пола · Ажурирано 13. 11. 2026. · NCT05920356

Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes

Тражи се учесникФаза 2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07672769

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Тражи се учесникФаза 1/2
  • NEXT Oncology ( Site 1011), Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT06818643

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 16 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07197554

A Study of YL242 in Subjects With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • US-203, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07197827

Childhood Cancer Predisposition Study (CCPS)

Тражи се учесникОпсервациона студија
  • Baylor College of Medicine, Houston
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT04511806

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Тражи се учесникФаза 1
  • Oncology Consultants /ID# 268323, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT05650632

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Тражи се учесникФаза 3
  • Houston Methodist Hospital, Houston
  • Memorial Hermann Texas Medical Center, Houston
  • Methodist Willowbrook Hospital, Houston
  • и још 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06580314

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Тражи се учесникФаза 3
  • Houston Methodist, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07195591

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT06983743

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
  • NEXT Texas LLC - Houston, Houston
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 11. 2026. · NCT07540572

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Тражи се учесникФаза 3
  • Houston Methodist Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06901531

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Тражи се учесникФаза 2
  • Kelsey-Seybold Clinic, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07169851

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06150157

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • Houston Methodist Hospital, Houston
  • University of Texas MD Anderson Cancer Center, Houston
  • Lumi Research, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06311578

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07578571

A Study of JNJ-1761981 in Participants With Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07525141

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Тражи се учесникФаза 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06801041

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Тражи се учесникФаза 2/3
  • The University of Texas Health Science Center at Houston, Houston
  • University of Texas- MD Anderson, Houston
Сви узрасти · Оба пола · Ажурирано 2. 11. 2026. · NCT03435796

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Тражи се учесникФаза 2
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06010329

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06959706

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2
  • University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
1 Month – 17 Years · Оба пола · Ажурирано 30. 10. 2026. · NCT07630974

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Тражи се учесникФаза 3
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст од 18 до 71 · Оба пола · Ажурирано 30. 10. 2026. · NCT07504458

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Мушкарци · Ажурирано 27. 10. 2026. · NCT05997615

A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

Тражи се учесникФаза 2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06010342

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

Тражи се учесникФаза 2
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06108232

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Тражи се учесникФаза 1
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06835569

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Тражи се учесник
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT02984761

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Тражи се учесникФаза 2
  • MD Anderson Cancer Center, Houston
Узраст од 2 до 99 · Оба пола · Ажурирано 21. 10. 2026. · NCT05783323

Intratumoral N17350 in Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07339176

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

Тражи се учесникФаза 2/3
  • MD Anderson Cancer Centerr, Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06085716

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06162221

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Тражи се учесникФаза 2/3
  • Houston Methodist Hospital, Houston
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

Тражи се учесникФаза 1
  • Houston Methodist Hospital ( Site 0103), Houston
  • MD Anderson Cancer Center ( Site 0104), Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07030712

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Тражи се учесникФаза 1/2
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05123482

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06993844

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Тражи се учесникФаза 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT05386108

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Тражи се учесникФаза 2
  • The University of Texas MD Anderson Cancer Center /ID# 273539, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07023289

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Тражи се учесникФаза 2
  • Retina Consultants of Texas, Bellaire · 7 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT06643884

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

Тражи се учесникФаза 2
  • The University of Texas Health Science Center at Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT06831136

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Тражи се учесникОпсервациона студија
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05733091

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

Тражи се учесникФаза 2
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05064280

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT03328078

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Тражи се учесникФаза 3
  • Houston Metro Urology, Houston
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07480356

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

Тражи се учесникФаза 2
  • Baylor College of Medicine Medical Center ( Site 0004), Houston
  • Harris Health System ( Site 0040), Houston
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06979596

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

Тражи се учесникОпсервациона студија
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06329531

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Тражи се учесникФаза 1/2
  • University of Texas-MD Anderson Cancer Center ( Site 3007), Houston
1 Month – 17 Years · Оба пола · Ажурирано 6. 10. 2026. · NCT06941272

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Тражи се учесникФаза 2/3
  • The University of Texas MD Anderson Cancer Center /ID# 275107, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07005102

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Тражи се учесникФаза 1
  • The University of Texas - MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07192471

A Study of PHN-012 in Patients With Advanced Solid Tumors

Тражи се учесникФаза 1
  • PHN-012-001 Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT07127874

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Тражи се учесникОпсервациона студија
  • The University of Texas M.D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT05874921

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06884618

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Тражи се учесникФаза 3
  • Investigative Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06881992

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, Houston
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT07612176

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

Тражи се учесник
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2026. · NCT06667427

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Тражи се учесникФаза 3
  • The University of Texas MD Anderson Cancer Center /ID# 280070, Houston
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Тражи се учесникФаза 2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 12 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT02693535

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Тражи се учесникФаза 1/2
  • MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06128551

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

Тражи се учесникОпсервациона студија
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT05694650

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

Тражи се учесникОпсервациона студија
  • UT MD Anderson Cancer Center, Houston
Сви узрасти · Оба пола · Ажурирано 18. 9. 2026. · NCT07743476

Statins to Prevent Cancer Associated Blood Clots

Тражи се учесникФаза 4
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07303816

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Тражи се учесникФаза 2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04996875

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

Тражи се учесникФаза 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT06807593

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Тражи се учесникФаза 1/2
  • The University of Texas Md Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT06634589

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • UT MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06440005

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Тражи се учесникФаза 1
  • MD Anderson Cancer Center - University of Texas, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Тражи се учесникФаза 2
  • M D Anderson Cancer Center, Houston
Сви узрасти · Оба пола · Ажурирано 4. 9. 2026. · NCT02479698

A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)

Тражи се учесник
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT07298096

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
36 Months – 22 Years · Оба пола · Ажурирано 4. 9. 2026. · NCT03911388

PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

Тражи се учесник
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07444645

ORB-021 In Patients With Advanced Solid Tumors

Тражи се учесникФаза 1
  • MDAC, Houston
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06607939

Project: Every Child for Younger Patients With Cancer

Тражи се учесникОпсервациона студија
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
До 25 година · Оба пола · Ажурирано 25. 8. 2026. · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Тражи се учесникФаза 3
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT05335928

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Тражи се учесникОпсервациона студија
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT05904782

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

Тражи се учесник
  • MD Anderson, Houston
Узраст 18 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT06409065

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

Тражи се учесникФаза 1
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 8. 2026. · NCT07382817

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

Тражи се учесник
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст од 18 до 39 · Оба пола · Ажурирано 12. 8. 2026. · NCT07186556

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • The University of Texas, MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 11. 8. 2026. · NCT05592626

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

Тражи се учесникФаза 2
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT05879146

Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

Тражи се учесник
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 8. 2026. · NCT06760754

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Тражи се учесникФаза 2
  • Texas Childrens Hospital, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Узраст од 1 до 39 · Оба пола · Ажурирано 7. 8. 2026. · NCT05999994

IDOV-Immune for Advanced Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT06910657

New Assessment System in Measuring Symptom Distress in Cancer Patients

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 7. 2026. · NCT00505245

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Тражи се учесникФаза 2
  • MD Anderson Cancer Center, Houston
Узраст од 2 до 25 · Оба пола · Ажурирано 24. 7. 2026. · NCT06458036

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

Тражи се учесникЗдраве особе су добродошле
  • MD Anderson Cancer Center, Houston
Сви узрасти · Оба пола · Ажурирано 17. 7. 2026. · NCT05294302

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

Тражи се учесникФаза 3
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 16. 7. 2026. · NCT05053867

Decoupling Immunotherapy Toxicity and Cancer Response

Тражи се учесникОпсервациона студија
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 16. 7. 2026. · NCT07382752

Long-Term Follow-Up of Recipient of Gene Transfer Research

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • University of Texas MD Anderson Cancer Center, Houston
Сви узрасти · Оба пола · Ажурирано 15. 7. 2026. · NCT01492036

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Тражи се учесник
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 15. 7. 2026. · NCT01365169

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT05768139

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT07079631

Molecular Genetics Studies of Cancer Patients and Their Relatives

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Сви узрасти · Оба пола · Ажурирано 29. 6. 2026. · NCT04185935

A Multi Center Study of Sexual Toxicities After Radiotherapy

Тражи се учесникОпсервациона студија
  • M.D. Anderson Cancer Center, Houston
Узраст 18 и старији · Жене · Ажурирано 22. 6. 2026. · NCT05394428

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Тражи се учесник
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Узраст од 18 до 75 · Оба пола · Ажурирано 17. 6. 2026. · NCT05486572

Childhood Cancer Survivor Study

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital, Houston
Сви узрасти · Оба пола · Ажурирано 17. 6. 2026. · NCT01120353

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Тражи се учесникФаза 1
  • University of Texas MD Anderson Cancer Center /ID# 252004, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 6. 2026. · NCT04777994

Active Living After Cancer: Implementation Within Be Well Acres Homes

Тражи се учесник
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 1. 6. 2026. · NCT06907706

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 12 и старији · Оба пола · Ажурирано 27. 5. 2026. · NCT03093116

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Тражи се учесникФаза 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 5. 2026. · NCT03686124

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1
  • MDACC, Houston
Узраст 18 и старији · Оба пола · Ажурирано 8. 5. 2026. · NCT05954312

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст од 18 до 75 · Оба пола · Ажурирано 24. 4. 2026. · NCT06385925

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 20. 4. 2026. · NCT06326411

The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Grace Clinic, Houston
Узраст 35 и старији · Оба пола · Ажурирано 8. 4. 2026. · NCT07461493

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Тражи се учесникФаза 2
  • Houston Methodist Neal Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 3. 2026. · NCT07050771

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Тражи се учесникОпсервациона студија
  • Md Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 3. 2026. · NCT04075305

Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

Тражи се учесникФаза 2
  • Baylor St. Luke's Medical Center, Houston
  • Ben Taub Hospital (Harris Health Systems), Houston
Узраст 18 и старији · Оба пола · Ажурирано 2. 3. 2026. · NCT06435286

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

Тражи се учесник
  • M D Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 27. 2. 2026. · NCT05681026

Primary Tumor Research and Outcomes Network

Тражи се учесникОпсервациона студија
  • The University of Texas M.D. Anderson Cancer Center, Houston
Сви узрасти · Оба пола · Ажурирано 25. 2. 2026. · NCT02790983

Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

Тражи се учесникФаза 3
  • Houston Methodist Neal Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 18. 12. 2025. · NCT07290491

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

Тражи се учесникФаза 1
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст од 18 до 99 · Оба пола · Ажурирано 3. 12. 2025. · NCT07021898

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Тражи се учесникОпсервациона студија
  • MD Anderson Cancer Center, Houston
  • Texas Children's Hospital, Houston
Узраст 0 и старији · Оба пола · Ажурирано 14. 11. 2025. · NCT05024929

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Houston
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • Oncology Consultants, P.A., Houston
Узраст од 18 до 120 · Оба пола · Ажурирано 20. 10. 2025. · NCT06877884

Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

Тражи се учесник
  • Baylor College of Medicine- McNair Campus, Houston
  • Baylor College of Medicine, Houston
  • Ben Taub General Hospital, Houston
  • и још 1
Узраст од 18 до 90 · Жене · Ажурирано 15. 10. 2025. · NCT04586959

A Study of NX-1607 in Adults With Advanced Malignancies

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2025. · NCT05107674

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 18. 5. 2025. · NCT05970497

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Тражи се учесникФаза 1/2
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 1. 5. 2025. · NCT04503265

Trial of DFP-14927 in Advanced Solid Tumors

Тражи се учесникФаза 1
  • MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 3. 3. 2025. · NCT03943004

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Тражи се учесникФаза 1/2
  • Oncology Consultants, P.A., Houston
  • The University of Texas M. D. Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 2. 2025. · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Тражи се учесник
  • The University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 27. 11. 2024. · NCT03860883

HPV Vaccine, Imiquimod, and Metformin Combination Trial

Тражи се учесникФаза 2
  • Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
  • Harris Health Smith Clinic, Houston
Узраст од 18 до 64 · Жене · Ажурирано 13. 11. 2024. · NCT06686043

A Study in Patients With Advanced Cancers

Тражи се учесникФаза 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 7. 2022. · NCT05320588

Studije za Рак (све врсте) u drugim gradovima

Ostale studije u gradu Houston

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.